851627-80-0

851627-80-0 structure
851627-80-0 structure
  • Name: PR-104 sodium
  • Chemical Name: Sodium 2-({2-[(2-bromoethyl){2-[(methylsulfonyl)oxy]ethyl}amino]- 3,5-dinitrobenzoyl}amino)ethyl hydrogen phosphate
  • CAS Number: 851627-80-0
  • Molecular Formula: C14H19BrN4NaO12PS
  • Molecular Weight: 601.25300
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage DNA Alkylator/Crosslinker
  • Create Date: 2016-05-18 07:21:54
  • Modify Date: 2024-01-10 16:55:03
  • PR-104 (sodium) is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104 (sodium), as a nitrogen mustard pre-prodrug, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A[1].

Name Sodium 2-({2-[(2-bromoethyl){2-[(methylsulfonyl)oxy]ethyl}amino]- 3,5-dinitrobenzoyl}amino)ethyl hydrogen phosphate
Description PR-104 (sodium) is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104 (sodium), as a nitrogen mustard pre-prodrug, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A[1].
Related Catalog
In Vitro PR-104 (sodium) (80 μM; 1 hour; SiHa cells) shows greater suppression of radiation-induced DNA single-strand breaks under hypoxic than aerobic conditions. PR-104 (sodium) (100 μM; 1 hour; SiHa cells) results in phosphorylation of Ser139 of histone H2AX (gH2AX). PR-104 (sodium) (0.266 mmol/kg; 18 h; SiHa cells) shows activity against hypoxic cells after irradiation. PR-104 (sodium) varies in potency between cell lines, with the lowest IC50 (0.51 μmol/L) in H460 cells and highest (7.3 μmol/L) in PC3 prostate cells[1].
In Vivo PR-104 (sodium) (0.56 mmol/kg; i.v. or i.p.; 0~2 hours) makes the plasma area under the curve. PR-104 (sodium) (0.23 mmol/kg; i.p.; 100 days) shows antitumor activity[1]. Animal Model: CD-1nu/nu mice Dosage: 0.56 mmol/kg (Pharmacokinetics Analysis) Administration: I.v. or i.p. Result: The plasma area under the curve. Animal Model: CD1-Foxn1nu mice Dosage: 0.23 mmol/kg Administration: I.p. Result: Showed antitumor activity.
References

[1]. Patterson AV, et al. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104. Clin Cancer Res. 2007;13(13):3922-3932.

Molecular Formula C14H19BrN4NaO12PS
Molecular Weight 601.25300
Exact Mass 599.95400
PSA 258.62000
LogP 3.09410
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.